Medication info

Samsung Bi Tablet 10/10mg

Prescription medicationTabletOralExpired
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Samsung Pharmaceutical Co., Ltd.
Appearance
White to pale yellow, biconvex, rectangular tablets
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Expired

MFDS item code 201900196 · Approved 2019.01.16

This product's status changed to Expired on 2024.01.16. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of mixed dyslipidemia and hypercholesterolemia (primary and homozygous familial)
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, without regard to meals. Patients with primary hypercholesterolemia The dose range is 10/10 mg to 10/40 mg once daily. The usual recommended starting dose is 10/20 mg once daily. Patients who require less LDL cholesterol reduction may start at 10/10 mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or longer. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see section 1, Warnings, under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section 4, General Precautions, subsection on patients with abnormal liver function, under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20 mg of this medicine once daily in the evening. Use caution and closely monitor these patients when administering higher doses of this medicine (see section 4, General Precautions, under Precautions for Use). Administration to older adults No dose adjustment is required in older adults. Concomitant administration with other medicines (See section 5, Interactions, under Precautions for Use.) Administer this medicine at least 2 hours before or 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10 mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20 mg/day of this medicine.

Ingredients

Manufacturer
Samsung Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of mixed dyslipidemia and hypercholesterolemia (primary and homozygous familial)

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This medication is used as an adjunct to dietary measures to lower total cholesterol, LDL cholesterol, ApoB protein, and triglycerides, and to increase HDL cholesterol in patients with primary hypercholesterolemia and mixed hyperlipidemia. In patients with homozygous familial hypercholesterolemia, it may be used as an adjunct to other lipid-lowering therapies or can be used alone if other treatments are not effective. Appropriate dietary measures and non-pharmacological interventions should be prioritized when administering this medication, and other causes of dyslipidemia should be ruled out. Careful use is required in patients at high risk of atherosclerotic cardiovascular disease due to hypercholesterolemia, and a lipid test prior to treatment is essential for accurate diagnosis. This medication helps improve blood lipid levels when combined with a proper lifestyle.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, without regard to meals. Patients with primary hypercholesterolemia The dose range is 10/10 mg to 10/40 mg once daily. The usual recommended starting dose is 10/20 mg once daily. Patients who require less LDL cholesterol reduction may start at 10/10 mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or longer. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see section 1, Warnings, under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section 4, General Precautions, subsection on patients with abnormal liver function, under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20 mg of this medicine once daily in the evening. Use caution and closely monitor these patients when administering higher doses of this medicine (see section 4, General Precautions, under Precautions for Use). Administration to older adults No dose adjustment is required in older adults. Concomitant administration with other medicines (See section 5, Interactions, under Precautions for Use.) Administer this medicine at least 2 hours before or 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10 mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20 mg/day of this medicine.

Precautions

This medication is primarily used to lower blood cholesterol levels. However, caution is needed as it may cause muscle-related issues during use. If muscle pain or weakness occurs, consult a doctor immediately. This medication should not be taken by individuals with liver disease or elevated liver enzymes. Women who are pregnant or breastfeeding should not take this medication. The risk of side effects may increase when taken with certain other medications, so inform your doctor if you are taking other medications. Elderly patients or those with impaired kidney function should also use it with caution, and regular blood tests to monitor liver and muscle status are recommended. There is no specific antidote for overdose, so comply with the prescribed dosage and consult medical personnel immediately if abnormal symptoms appear. Finally, it is advisable to avoid certain foods like grapefruit juice during the medication period.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 96 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • weakness
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • dysgeusia
  • ophthalmoplegia
  • facial paresis
  • tremor
  • dizziness
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disturbances
  • nightmares
  • depression
  • cognitive impairment
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus-like erythema
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • arthralgia
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • lethargy
  • dyspnea
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • pancreatitis
  • hepatitis
  • gallbladder bile stasis jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • hepatocellular carcinoma
  • hepatic failure
  • anorexia
  • vomiting
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • oculomotor paralysis
  • anemia
  • elevated aminotransferases
  • increased ALP
  • elevated gamma-GT
  • increased bilirubin levels
  • abnormal thyroid function
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial swelling
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucus stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • increased serum creatine phosphokinase
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is important to store it at room temperature between 1°C and 30°C to maintain its effectiveness.

Appearance and packaging

Appearance

White to pale yellow, biconvex, rectangular tablets

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.